Initial strategy of catheter ablation leads to lower risk for composite primary end point versus antiarrhythmic drug therapy ...
Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce that, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback